Gilead Sciences Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio239.8317.8223.4514.63593.74
Forward P/E12.5510.8812.9010.798.59
P/S Ratio4.003.723.953.342.96
P/B Ratio5.984.445.084.324.01
Price/FCF11.1713.6012.908.439.71
Price/OCF10.6312.6111.878.008.94
PEG Ratio0.740.938.423.04
Enterprise Value Ratios
EV/Revenue4.584.304.594.073.05
EV/EBITDA9.789.759.597.946.05
EV/EBIT12.3112.5811.429.316.87
EV/FCF12.7715.7315.0210.2810.02
Profitability & Returns
Return on Equity (ROE)0.02%0.26%0.22%0.32%0.00%
Return on Assets (ROA)0.11%0.09%0.10%0.11%0.11%
Return on Invested Capital (ROIC)0.20%0.19%0.21%0.22%0.02%
Return on Capital Employed (ROCE)0.23%0.18%0.21%0.21%0.19%
Leverage & Solvency Ratios
Debt/Equity1.421.131.221.291.76
Debt/EBITDA2.012.111.951.932.55
Debt/FCF2.653.463.092.524.27
Liquidity Ratios
Current Ratio1.601.431.281.271.40
Quick Ratio1.331.151.031.021.20
Efficiency Ratios
Asset Turnover0.470.430.420.400.38
Inventory Turnover3.583.653.623.352.83
Yield & Distribution Ratios
Earnings Yield0.00%0.06%0.04%0.07%0.00%
FCF Yield0.09%0.07%0.08%0.12%0.10%
Dividend Yield0.03%0.04%0.04%0.05%0.06%
Payout Ratio8.16%0.67%0.81%0.58%28.04%
Buyback Yield0.00%0.00%0.00%0.00%0.01%
Total Return0.04%0.04%0.04%0.05%0.07%